Thus, this systematic review aims to evaluate the SLC6A3 (DAT1) 3′UTR VNTR (rs28363170) genetic variant influence on MDD, as such information might help identify risk factors to assist in new forms of diagnosis, treatment, and ways to improve the quality of life of patients with psychopathology. This evidence concerns the gene SLC6A3 and major depressive disorder.